Market Place
Sourcing Support
Roche Commits $100M To Keep Its GLP-1 Structure Sound
06 Jan 2026 //
FIERCE BIOTECH
FDA Approves Roche`s Lunsumio VELO For Subcutaneous Use
22 Dec 2025 //
GLOBENEWSWIRE
Roche CEO Points to Higher Future Drug Prices in Switzerland
20 Dec 2025 //
REUTERS
Caris, Genentech Collaborate on Novel Cancer Targets
16 Dec 2025 //
PR NEWSWIRE
FDA Approves Roche`s ENHERTU for HER2+ Metastatic Breast Cancer
16 Dec 2025 //
PR NEWSWIRE
Roche Launches Next-Gen Cobas 6800/8800 in U.S
16 Dec 2025 //
PR NEWSWIRE
Natera and MEDSIR to Collaborate on the MiRaDoR Trial
12 Dec 2025 //
BUSINESSWIRE
Roche Expands Mass Spectrometry Menu With Antibiotics Monitoring
11 Dec 2025 //
GLOBENEWSWIRE
Genentech`s Giredestrant Cuts Er-Positive Breast Cancer
10 Dec 2025 //
BUSINESSWIRE
Roche Links SERD to 30% Breast Cancer Risk Reduction in Phase 3
10 Dec 2025 //
GLOBENEWSWIRE
Genentech Uncovers `Hidden Gems` In Latest #Msvisibility Drive
09 Dec 2025 //
FIERCE PHARMA
Europe Approves Roche`s Gazyva For Active Lupus Nephritis
09 Dec 2025 //
GLOBENEWSWIRE
Roche Launches CE-Marked PCR Test for Vaginitis
09 Dec 2025 //
GLOBENEWSWIRE
Roche Reveals Lunsumio Data Suggesting Promise In Early Lymphoma
08 Dec 2025 //
GLOBENEWSWIRE
Genentech Reveals Lunsumio Data In Early Lymphoma Treatment Lines
08 Dec 2025 //
BUSINESSWIRE
Roche`s Columvi Combo Demonstrates Long-Term Survival Benefit
08 Dec 2025 //
GLOBENEWSWIRE
Orano Med Enters Next Phase Of Collaboration With Roche
04 Dec 2025 //
PHARMIWEB
Roche Whooping Cough Test Greenlighted In US, Europe
03 Dec 2025 //
FIERCE BIOTECH
Roche Reenters Alzheimer`s With New Antibody Clearing Amyloid
02 Dec 2025 //
BIOSPACE
Roche`s Alzheimer`s Reentry Marks A Pivotal Moment
02 Dec 2025 //
BIOSPACE
Actinium Reveals ATNM-400`s Strong Efficacy in Breast Cancer
01 Dec 2025 //
PR NEWSWIRE
Veeva Announces Expanded Partnership With Roche
24 Nov 2025 //
PR NEWSWIRE
Roche Inks $200M Pact For Freenome`s Cancer Screening Blood Test
21 Nov 2025 //
FIERCE BIOTECH
KaliVir & Roche Partner To Test VET3-TGI With Atezolizumab
19 Nov 2025 //
BUSINESSWIRE
European Commission Greenlights Roche`s Lunsumio Subcutaneous
19 Nov 2025 //
GLOBENEWSWIRE
Freenome & Roche Expand Cancer Screening Test Collaboration
18 Nov 2025 //
PR NEWSWIRE
Genentech`s Giredestrant Shows Superior iDFS in Breast Cancer
18 Nov 2025 //
BUSINESSWIRE
Poherdy, First Biosimilar To Roche`s Perjeta, Scores FDA Nod
14 Nov 2025 //
FIERCE PHARMA
NICE Endorses Roche`s Columvi For Earlier Use
13 Nov 2025 //
FIERCE PHARMA
Eirgenix Signs Commercial Licensing Deal For HER2 Biosimilar
12 Nov 2025 //
PR NEWSWIRE
Apollo 24|7 Partners With L`Oreal To Introduce La Roche-Posay
10 Nov 2025 //
ECONOMICTIMES
Roche`s Experimental MS Drug Hits Main Goal in One of Two Trial
09 Nov 2025 //
BUSINESSWIRE
Positive Phase III Data for Genentech’s Gazyva for Lupus
03 Nov 2025 //
BUSINESSWIRE
Roche To Unveil Innovative Hematology Data at ASH 2025
03 Nov 2025 //
GLOBENEWSWIRE
Manifold Bio Announces Strategic Collaboration with Roche
03 Nov 2025 //
BUSINESSWIRE
Roche`s Gazyva Tees Up Another Lupus Expansion With Phase 3 Win
03 Nov 2025 //
FIERCE PHARMA
Roche Purchases Shares In Tender Offer For 89Bio
30 Oct 2025 //
GLOBENEWSWIRE
Roche Pens $1B Deal For Respiratory Bispecific From China
30 Oct 2025 //
FIERCE BIOTECH
Roche Gets CE Mark for Elecsys Dengue Ag High-Throughput Test
29 Oct 2025 //
GLOBENEWSWIRE
Roche`s Flatiron Health Debuts 6 New Blood Cancer Data Sets
29 Oct 2025 //
FIERCE BIOTECH
Roche`s Gazyva/Gazyvaro Shows Positive Phase III Results
28 Oct 2025 //
GLOBENEWSWIRE
Roche Pads Case For Gazyva In Immune-Mediated Kidney Conditions
28 Oct 2025 //
FIERCE PHARMA
Roche Axes 4 Chugai Solid Tumor Assets In Early-Phase Clear-Out
24 Oct 2025 //
FIERCE BIOTECH
Roche Sustains 7% Sales Growth, Boosts Full-Year Earnings Outlook
23 Oct 2025 //
GLOBENEWSWIRE
Changes To The Roche Enlarged Corporate Executive Committee
23 Oct 2025 //
GLOBENEWSWIRE
Roche Overcomes Drug-Specific Struggles, Currency Woes In Q3
23 Oct 2025 //
FIERCE PHARMA
Roche Raises Profit View, but Weak Dollar Weighs on Sales
23 Oct 2025 //
REUTERS
Roche Unveils Positive Ph 3 Results For Vamikibart In UME Edema
22 Oct 2025 //
INDPHARMAPOST
Roche’s Gazyva Expands Out of Cancer With FDA Approval for Lupus
22 Oct 2025 //
BIOSPACE
Exelixis Kinase Blocker Sets Survival Bar In Colorectal Cancer
21 Oct 2025 //
PRESS RELEASE
Ventus Pharma Collaborates With Genentech On Small-Molecule
21 Oct 2025 //
BUSINESSWIRE
ESMO: The ADC `Rollercoaster` Rides On With Next-Gen Meds
21 Oct 2025 //
FIERCE BIOTECH
Genentech`s Tecentriq Demonstrates Major Survival Gains
20 Oct 2025 //
PHARMIWEB
EMPRESS Study Shows Giredestrant Cut Tumor Growth in Early Cancer
20 Oct 2025 //
PR NEWSWIRE
Roche Heads To FDA As Eye Disease Trials Yield Mixed Data
20 Oct 2025 //
FIERCE BIOTECH
ESMO: Merck Lays Out Keytruda`s Landmark Win In Ovarian Cancer
18 Oct 2025 //
FIERCE PHARMA
ESMO: Roche Wants Oral SERD To Benefit `All Comers`
18 Oct 2025 //
FIERCE BIOTECH
ESMO: Enhertu Wields 2-Fisted Power In Early Breast Cancer
18 Oct 2025 //
FIERCE PHARMA
Genentech Presents Ph3 Data for Vamikibart in UME
17 Oct 2025 //
PHARMIWEB
CHMP Backs Roche`s Gazyva For Lupus Nephritis In EU
17 Oct 2025 //
GLOBENEWSWIRE
